Phlexglobal Launches Research Nurse Bank
Phlexglobal
, has broadened its personnel provision with the launch of a new Research Nurse Bank.
Following client requests, the Research Nurse Bank has been opened to supply skilled nursing staff on a temporary basis to both commercial and NHS clients. With experience of providing clinical research support at the client’s site, the nurses will be available for all phases of clinical trials.
The new initiative is an extension to Phlexglobal’s Task Force, which supplies experienced clinical research personnel, including CRAs, CTAs, QA personnel, research governance assistants/managers and document managers for interim and short term projects.
To compliment the new Task Force extension, Phlexglobal’s training division has added a new research nurse training program to its recently launched training curriculum, which specialzses in tuition for nurses wishing to move into the clinical research field (Essential Skills for Clinical Researchers: Research Nurse), as well as ongoing development for experienced nurses (Advanced Skills for Research Nurses).
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
